Age-related changes in ADMA–DDAH–NO pathway in rat liver subjected to partial ischemia followed by global reperfusion

作者: Małgorzata Trocha , Anna Merwid-Ląd , Ewa Chlebda-Sieragowska , Andrzej Szuba , Małgorzata Pieśniewska

DOI: 10.1016/J.EXGER.2013.11.004

关键词:

摘要: Abstract Background Liver function is affected during ischemia/reperfusion (IR). We evaluated the effect of aging process on selected parameters determining NO level in rat liver subjected to IR. Methods The animals were divided into C-2 and IR-2 group young rats (2–4 months old) C-12 IR-12 older (12–14 months old). Livers belonging partial ischemia (60 min) reperfusion (4 h). Blood samples obtained after surgeries estimate activity aminotransferases, as well just before (15, 120, 240 min) concentration arginine (Arg) its derivatives: asymmetric symmetric dimethylarginine (ADMA, SDMA). After IR, dimethylaminohydrolase (DDAH) protein inducible nitric oxide synthase (iNOS) measured homogenates. Results In ADMA increased most between 15 120 min was highest all groups (0.72 ± 0.2 μmol/l). decreased significantly lower compared other at 15 min (0.42 ± 0.2 μmol/l) 120 (0.52 ± 0.1 μmol/l) 240 min (0.38 ± 0.1 μmol/l) reperfusion. Only SDMA (0.75 ± 0.9 μmol/l) (1.0 ± 1.2 μmol/l) At beginning surgery Arg higher (C-2: 102.1 ± 35.7 μmol/l; IR-2: 114.63 ± 28.9 μmol/l) than ones (C-12: 41.88 ± 44.7 μmol/l; IR-12: 28.64 ± 30.6 μmol/l). (77.41 ± 37.5 μmol/l) Arg/ADMA (A/A) ratio (138.03 ± 62.8 μmol/l) ischemic (Arg: 47.17 ± 31.7 μmol/l; A/A: 88.28 ± 66.2 μmol/l) 43.87 ± 21.9 μmol/l; 118.02 ± 106.3 μmol/l). (11.4 ± 12.0 μmol/l) A/A (16.11 ± 16.2 μmol/l) next phase levels those low, comparably IR-12. As a result decrease DDAH an increase iNOS observed only rats. Conclusions found that non-ischemic may be by process. Under IR conditions, important changes DDAH–ADMA–NO pathway livers.

参考文章(54)
Anetta Undas, Paweł P Dimitrow, Jacek S Dubiel, Wiesława Tracz, Maria Bober, Plasma biomarkers of endothelial dysfunction in patients with hypertrophic cardiomyopathy. Pharmacological Reports. ,vol. 59, pp. 715- 720 ,(2007)
E N Standfield, L D Buttery, J M Polak, T J Evans, M H Yacoub, D V Parums, D R Springall, A H Chester, Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite Laboratory Investigation. ,vol. 75, pp. 77- 85 ,(1996)
Louis J. Ignarro, Endothelium-derived nitric oxide: actions and properties. The FASEB Journal. ,vol. 3, pp. 31- 36 ,(1989) , 10.1096/FASEBJ.3.1.2642868
V Shah, F G Haddad, G Garcia-Cardena, J A Frangos, A Mennone, R J Groszmann, W C Sessa, Liver Sinusoidal Endothelial Cells Are Responsible for Nitric Oxide Modulation of Resistance in the Hepatic Sinusoids Journal of Clinical Investigation. ,vol. 100, pp. 2923- 2930 ,(1997) , 10.1172/JCI119842
Barbara Alkofer, Benjamin Samstein, James Guarrera, Cindy Kin, Dominique Jan, Sarah Bellemare, Milan Kinkhabwala, Robert Brown, Jean Emond, John Renz, Extended-donor criteria liver allografts. Seminars in Liver Disease. ,vol. 26, pp. 221- 233 ,(2006) , 10.1055/S-2006-947292
Seiji Ueda, Seiya Kato, Hidehiro Matsuoka, Masumi Kimoto, Seiya Okuda, Minoru Morimatsu, Tsutomu Imaizumi, Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circulation Research. ,vol. 92, pp. 226- 233 ,(2003) , 10.1161/01.RES.0000052990.68216.EF
Ellen S. Kang, Marjorie T. Tevlin, Yu Bo Wang, Thomas M. Chiang, Raul Cardenas, Linda K. Myers, Sergio R. Acchiardo, Hemodialysis Hypotension: Interaction of Inhibitors, iNOS, and the Interdialytic Period The American Journal of the Medical Sciences. ,vol. 317, pp. 9- 21 ,(1999) , 10.1016/S0002-9629(15)40465-3
S. Feng, N.P. Goodrich, J.L. Bragg-Gresham, D.M. Dykstra, J.D. Punch, M.A. DebRoy, S.M. Greenstein, R.M. Merion, Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation. ,vol. 6, pp. 783- 790 ,(2006) , 10.1111/J.1600-6143.2006.01242.X